PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
May 20, 2026American Journal of Respiratory and Critical Care Medicine

A72-13 Fibrotic Lung Disease in Cystic Fibrosis: The Overlooked Role of Vaping and COVID-19

View Full Paper
Ask AI
Bookmark
Share

Authors

GKG KurianNCN Chaudary

Discussion

Loading...

Member takes

Overview

Case report identifies vaping and SARS-CoV-2 as factors worsening lung fibrosis in cystic fibrosis patients, highlighting clinical implications.

Key Points

  • This report investigates the relationship between vaping, COVID-19, and fibrotic lung disease in cystic fibrosis patients.
  • Case report of a 52-year-old male with cystic fibrosis, detailing clinical history and imaging findings.
  • Assessment of lung structure via chest CT and examination of symptoms related to e-cigarette use and viral infection.
  • Review of treatment approach including antibiotics and corticosteroids.
  • Patient exhibited worsening respiratory symptoms and imaging consistent with fibrotic lung disease.
  • Chronic exposure to vaping and recent COVID-19 infection were noted as exacerbating factors.
  • The patient showed stable fibrotic changes over a two-year follow-up period after treatment.

Cite This Study

Kurian et al. (2026) studied this question.

synapsesocial.com/papers/6a0d5064f03e14405aa9c2c6https://doi.org/10.1093/ajrccm/aamag162.2129
View Full Paper
Ask AI
Bookmark
Share